Chimerix Inc (CMRX)
1.03
+0.04
(+4.04%)
USD |
NASDAQ |
Nov 05, 11:27
Chimerix Cash from Investing (Quarterly): 14.36M for June 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 14.36M |
| March 31, 2024 | 8.675M |
| December 31, 2023 | 28.07M |
| September 30, 2023 | 11.87M |
| June 30, 2023 | 18.52M |
| March 31, 2023 | 12.14M |
| December 31, 2022 | -228.40M |
| September 30, 2022 | 238.27M |
| June 30, 2022 | 6.70M |
| March 31, 2022 | 53.47M |
| December 31, 2021 | 23.19M |
| September 30, 2021 | 15.46M |
| June 30, 2021 | 5.971M |
| March 31, 2021 | -88.72M |
| December 31, 2020 | 17.56M |
| September 30, 2020 | -7.332M |
| June 30, 2020 | 36.24M |
| March 31, 2020 | 18.24M |
| December 31, 2019 | 1.02M |
| September 30, 2019 | 39.70M |
| June 30, 2019 | 15.74M |
| March 31, 2019 | -45.83M |
| December 31, 2018 | 66.04M |
| September 30, 2018 | -2.206M |
| June 30, 2018 | 19.32M |
| Date | Value |
|---|---|
| March 31, 2018 | 21.94M |
| December 31, 2017 | 12.55M |
| September 30, 2017 | 5.323M |
| June 30, 2017 | 14.92M |
| March 31, 2017 | -16.37M |
| December 31, 2016 | 11.79M |
| September 30, 2016 | 29.82M |
| June 30, 2016 | 17.09M |
| March 31, 2016 | 35.37M |
| December 31, 2015 | 9.313M |
| September 30, 2015 | -58.11M |
| June 30, 2015 | -65.98M |
| March 31, 2015 | -54.72M |
| December 31, 2014 | -44.13M |
| September 30, 2014 | -33.94M |
| June 30, 2014 | -18.89M |
| March 31, 2014 | -62.74M |
| December 31, 2013 | 0.931M |
| September 30, 2013 | 6.495M |
| June 30, 2013 | 3.191M |
| March 31, 2013 | -1.155M |
| December 31, 2012 | -9.912M |
| September 30, 2012 | -0.08M |
| June 30, 2012 | -0.035M |
| March 31, 2012 | 5.888M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-228.40M
Minimum
Dec 2022
238.27M
Maximum
Sep 2022
9.753M
Average
14.36M
Median
Jun 2024
Cash from Investing (Quarterly) Benchmarks
| SIGA Technologies Inc | -0.0022M |
| Abbott Laboratories | -594.00M |
| Emergent BioSolutions Inc | -4.60M |
| Tonix Pharmaceuticals Holding Corp | 0.00 |
| Geovax Labs Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -17.68M |
| Cash from Financing (Quarterly) | -0.042M |
| Free Cash Flow | -67.84M |
| Free Cash Flow Per Share (Quarterly) | -0.1981 |
| Free Cash Flow to Equity (Quarterly) | -17.75M |
| Free Cash Flow Yield | -73.91% |